4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-001167
EVP, GM Gene Therapy sold 27,923 shares at $4.55 ($127,050)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Buck Jill EVP, GM Gene Therapy | 2020-01-02 | Sale | −27,923 | $4.55 | $127,050 | 173,710 | D |
| Open-market sales · 27,923 sh · avg $4.55 · $127,050 | |||||||
Loading xslF345X03/doc4.xml…